Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.

TitleIdentification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.
Publication TypeJournal Article
Year of Publication2015
AuthorsFrigault MJ, Lee J, Basil MCiocca, Carpenito C, Motohashi S, Scholler J, Kawalekar OU, Guedan S, McGettigan SE, Posey AD, Ang S, Cooper LJN, Platt JM, F Johnson B, Paulos CM, Zhao Y, Kalos M, Milone MC, June CH
JournalCancer Immunol Res
Volume3
Issue4
Pagination356-67
Date Published2015 Apr
ISSN2326-6074
KeywordsAnimals, CD28 Antigens, CD3 Complex, Cell Proliferation, Chemokines, Cytokine-Induced Killer Cells, Cytokines, Female, Genetic Vectors, Humans, Immunophenotyping, Immunotherapy, Adoptive, Interleukin-2, Lentivirus, Lymphocyte Activation, Mice, Inbred NOD, Mice, SCID, Ovarian Neoplasms, Receptors, Antigen, T-Cell, Recombinant Fusion Proteins, Signal Transduction, T-Lymphocytes, Xenograft Model Antitumor Assays
Abstract

This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-κB, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials.

DOI10.1158/2326-6066.CIR-14-0186
Alternate JournalCancer Immunol Res
PubMed ID25600436
PubMed Central IDPMC4390458
Grant ListP01 CA066726 / CA / NCI NIH HHS / United States
2P30CA016520 / CA / NCI NIH HHS / United States
R01 CA105216 / CA / NCI NIH HHS / United States
R01 CA175061 / CA / NCI NIH HHS / United States
P01CA066726 / CA / NCI NIH HHS / United States
R01CA105216 / CA / NCI NIH HHS / United States
P30 CA016520 / CA / NCI NIH HHS / United States
P01 CA148600 / CA / NCI NIH HHS / United States
R01 CA165206 / CA / NCI NIH HHS / United States
2PN2EY016586 / EY / NEI NIH HHS / United States
R01CA120409 / CA / NCI NIH HHS / United States
PN2 EY016586 / EY / NEI NIH HHS / United States
T32 HL007586 / HL / NHLBI NIH HHS / United States
3T32GM007170-36S1 / GM / NIGMS NIH HHS / United States
T32 GM007170 / GM / NIGMS NIH HHS / United States
R01 CA120409 / CA / NCI NIH HHS / United States